Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling

Background: Chemotherapy remains a primary treatment method for advanced pancreatic cancer. However, chemotherapy resistance can influence the therapeutic effect of pancreatic cancer. The resistance mechanism of chemotherapeutic agents such as gemcitabine, which is an agent typically used to treat p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bili, Shen, Can, Li, Yang, Zhang, Ting, Huang, Hui, Ren, Jun, Hu, Zhengjun, Xu, Jian, Xu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645696/
https://www.ncbi.nlm.nih.gov/pubmed/31410021
http://dx.doi.org/10.2147/OTT.S208924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645696/
https://www.ncbi.nlm.nih.gov/pubmed/31410021
http://dx.doi.org/10.2147/OTT.S208924

Ejemplares similares